An update: cancer-associated anorexia as a treatment target
- PMID: 11517349
- DOI: 10.1097/00075197-200105000-00002
An update: cancer-associated anorexia as a treatment target
Abstract
Loss of appetite is pervasive among patients with advanced cancer. Cancer patients cite it as one of their most troubling symptoms. To date, however, palliative options remain limited. Megestrol acetate and dexamethasone provide only modest relief. Novel agents such as thalidomide, adenosine triphosphate, and other cytokine inhibitors merit further investigation.
Comment in
-
A deadly combination of anorexia and hypermetabolism.Curr Opin Clin Nutr Metab Care. 2001 May;4(3):175-7. doi: 10.1097/00075197-200105000-00001. Curr Opin Clin Nutr Metab Care. 2001. PMID: 11517348 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
